Simcere Pharmaceutical Group Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
886.00
809.00
1,030.00
1,742.00
920.00
1,236.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-92.00
-1,043.00
109.00
-922.00
-631.00
-387.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,592.00
486.00
1,874.00
-283.00
62.00
784.00
Cash Flow from Investing Activities
-1,280.00
854.00
-249.00
-556.00
493.00
-798.00
Cash Flow from Financing Activities
-414.00
-957.00
-830.00
-1,880.00
2,792.00
-988.00
Net Cash Inflow / Outflow
-100.00
388.00
811.00
-2,763.00
3,276.00
-1,002.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
2.00
5.00
17.00
-42.00
-71.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Simcere Pharmaceutical Group Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
886.58718359732
177.876679378148
709.00
398.43%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-92.8973830496187
1690.64541675774
-1,782.00
-105.49%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1592.3334198318
3389.56779832919
-1,797.00
-53.02%
Cash Flow from Investing Activities
-1280.84675211872
-532.864576101633
-748.00
-140.37%
Cash Flow from Financing Activities
-414.461911378783
-1317.55748720741
903.00
68.54%
Net Cash Inflow / Outflow
-100.496707961732
1539.40378029466
-1,639.00
-106.53%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
2.47853570396504
0.25804527451709
2.00
860.50%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 227.25% vs -74.04% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
1,592.33
486.58
227.25%






